Hepatic hemangioma is a relatively common benign tumor of the liver, with cavernous hemangioma being the most common clinically, accounting for 5-20% of benign liver tumors. Currently, it is believed that it is not a neoplastic lesion but a congenital malformation of the portal vein. Most cases of hepatic hemangioma are clinically asymptomatic or have mild symptoms, with a long course, slow growth and good prognosis. In recent years, with the improvement of people’s awareness of health checkups and the advancement of various diagnostic imaging techniques, the detection rate of asymptomatic small hemangiomas has increased significantly. Asymptomatic hepatic hemangiomas are small, they usually do not need treatment. As the scope of the lesion increases, it is generally believed that if the lesion is >4-5cm and the patient develops different degrees of clinical symptoms, the tumor should be treated and even affects liver function. Even affecting liver function, it should be treated. When tumor rupture occurs, it can be life-threatening. Therefore, it is critical that it should be treated actively. Now we mainly introduce the interventional therapy: interventional hepatic artery embolization for hepatic hemangioma is borrowed from the experience of TAE in treating hepatocellular carcinoma, the theory is based on the fact that hepatic hemangioma is mainly supplied by hepatic artery, and thrombus can be formed in the body of tumor after embolization of the artery, which can cause the tumor to form a fibrous tumour-like structure to achieve the purpose of narrowing and hardening the hemangioma. 1.What cases of hepatic hemangioma can be selected for interventional therapy? For hepatic hemangioma larger than 5cm, regardless of the location, scope and number. 2.What are the advantages of interventional therapy for hepatic hemangioma? (1) Wide indications, small damage, fast recovery and good curative effect. (2) Interventional therapy for hepatic hemangioma can prevent tumor rupture and bleeding. 3) There is no absolute contraindication. 4) In case of recurrence, it can be intervened again. 5) High safety. 3.How much is the cost of hepatic hemangioma intervention? Hepatic hemangioma intervention includes pre-interventional examination, interventional surgery fee, postoperative symptomatic treatment, general treatment cost is about 7000-9000 yuan, if the vascular variant needs microcatheter embolization, the cost increases slightly, and medical insurance can reimbursement! 4.Is there any pain in hepatic hemangioma interventional therapy, and what are the side effects? Hepatic hemangioma interventional therapy uses local anesthesia, and the whole operation process is known to patients. After the intervention embolization, some patients may have fever, distension and pain in the liver area and other discomforts, which are generally treated with symptomatic pain relief, and will be improved after the heat treatment is withdrawn. 5.How long do I need to be hospitalized for interventional therapy? If there is no accident, the patient will be discharged from the hospital within one week! 6.How is the effect of hepatic hemangioma treatment? Hepatic hemangioma treatment has less side effects and more accurate efficacy, and more and more patients are choosing it now. It is rare to see recurrence on follow-up. The following is a typical case of a huge hepatic hemangioma with distension and pain in the liver area, which was reduced in size after 2 years of interventional embolization, and iodine oil deposition was satisfactory!